Compare PAI & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAI | OPRX |
|---|---|---|
| Founded | 1973 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.9M | 96.1M |
| IPO Year | N/A | 2008 |
| Metric | PAI | OPRX |
|---|---|---|
| Price | $12.09 | $6.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 12.1K | ★ 486.8K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $11.72 | $4.54 |
| 52 Week High | $13.20 | $22.25 |
| Indicator | PAI | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 66.80 |
| Support Level | $12.05 | $5.80 |
| Resistance Level | $12.35 | $7.23 |
| Average True Range (ATR) | 0.07 | 0.36 |
| MACD | 0.00 | 0.15 |
| Stochastic Oscillator | 27.78 | 92.04 |
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.